LifeArc marks Rare Disease Day 2020 with a call for more translational research
Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…
Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back.
An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to start trials in patients thanks to the perseverance of the charity team at LifeArc.
Melanie Lee, LifeArc CEO, reflects on a career in life sciences leading to her win of the BIA Lifetime Achievement Award in 2019.
Here we look back at the experiences of last years’ alumni and hope to provide insight into the programme for future candidates.
(Blog first appeared on AMRC website on 4 December 2017. ) Mike Johnson, Executive Director, Business Development,…
Article in Nature Biotechnology about our new name and plans for the future (subscription needed to read…
Which treatment or diagnostic would make a patient’s life better? This is the starting point of what…
As we face the prospect of living in a ‘post-antibiotic’ era, there is renewed urgency to rethink…